Real-World Bleeding Risk of Anticoagulant and Nonsteroidal Anti-inflammatory Drugs Combotherapy versus Anticoagulant Monotherapy
Gut and Liver · 15.09.2024 · 18 (5) · 824-833
DOI: 10.5009/gnl230541 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Gut and Liver, online erschienen am 10.05.2024. Verfasst von Moonhyung Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Korea. Hauptthemen laut MEDLINE: Anticoagulants, Anti-Inflammatory Agents, Non-Steroidal, Gastrointestinal Hemorrhage, Drug Therapy, Combination. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Korea.
ORCID-Profile: Moonhyung Lee, Jae Myung Cha
Zitieren
APA
Lee, M., & Cha, J. M. (2024). Real-World Bleeding Risk of Anticoagulant and Nonsteroidal Anti-inflammatory Drugs Combotherapy versus Anticoagulant Monotherapy. Gut and Liver, 18(5), 824-833. https://doi.org/10.5009/gnl230541
Vancouver
Lee M, Cha JM. Real-World Bleeding Risk of Anticoagulant and Nonsteroidal Anti-inflammatory Drugs Combotherapy versus Anticoagulant Monotherapy. Gut and Liver. 2024;18(5):824-833. doi:10.5009/gnl230541
BibTeX
@article{Lee2024,
author = {Lee, Moonhyung and Cha, Jae Myung},
title = {Real-World Bleeding Risk of Anticoagulant and Nonsteroidal Anti-inflammatory Drugs Combotherapy versus Anticoagulant Monotherapy},
journal = {Gut and Liver},
year = {2024},
volume = {18},
number = {5},
pages = {824--833},
doi = {10.5009/gnl230541}
}
EUVIMED